Skip to content

Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma

Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062442
Enrollment
Unknown
Registered
2022-08-07
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagogastric junction adenocarcinoma

Interventions

Observation group:N/A

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
27 Years to 86 Years

Inclusion criteria

Inclusion criteria: 1. During the period from 2010 to 2020, the preoperative evaluation was in line with the absolute and expanded indications of ESD treatment, and the biopsy pathology showed early-stage adenocarcinoma of the cardia and received ESD or surgery; 2. Take EGJ adenocarcinoma as the first primary tumor; 3. The survival status and survival time are clear.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of gastric surgery or a history of receiving antitumor therapy; 2. Those who are confirmed to have lymph node or distant metastasis; 3. Suffering from other primary malignant tumors at the same time, such as lung cancer, liver cancer, breast cancer, etc.; 4. The follow-up time is less than 6 months; 5. Incomplete clinical, endoscopic, and pathological data.

Design outcomes

Primary

MeasureTime frame
Survival rate;

Countries

China

Contacts

Public ContactZhou Xiaoying

Jiangsu Province Hospital

zhouxiaoying0926@sina.cn+86 15850668395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026